SCHEMBL23970933

SCHEMBL23970933

COC(=O)c1cc(N)c(NC2CC2OC)cc1F

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.38
KDM4E B2RXH2 7/20 0.38
MAPT P10636 5/20 0.38
GAA P10253 5/20 0.38
HPGD P15428 5/20 0.38
HSD17B10 Q99714 4/20 0.38
GLA P06280 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ATM Q13315 1/20 0.38
MAPK1 P28482 1/20 0.36
CFTR P13569 3/20 0.35
ABL1 P00519 1/20 0.35
TSHR P16473 3/20 0.34
ALOX15 P16050 1/20 0.34
NPC1 O15118 3/20 0.33
RAB9A P51151 3/20 0.33
ROCK2 O75116 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23971024 0.87 KDM4E (0.38) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL23971182 0.87 KDM4E (0.38) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL23971180 0.87 KDM4E (0.38) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL30850093 0.81 ROCK2 (0.51) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL23970709 0.81 ROCK2 (0.51) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL2248317 0.76 KDM4E (0.46) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL23971181 0.75 KDM4E (0.39) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL17010488 0.75 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL17010487 0.75 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTGAAHPGD
SCHEMBL17010485 0.75 ALDH1A1 (0.37) ALDH1A1KDM4EMAPTGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. 2023-01-05 US disclosed
WO-2021222353-A1 MACROCYCLIC INHIBITORS OF PEPTIDYLARGININE DEIMINASES GILEAD SCIENCES, INC. (US) 2021-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230002412-A1 INHIBITORS OF PEPTIDYLARGININE DEIMINASES PADI4, PADI2, PADI1 ALDH1A1 2537/4885KDM4E 936/4885MAPT 3578/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.